ANTIGENICS INC. 9,500,000 Shares Of Common Stock At Market Issuance Sales AgreementAntigenics Inc /De/ • March 14th, 2008 • Biological products, (no disgnostic substances) • New York
Antigenics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Wm Smith & Co. (“Wm Smith” and together with the Company, the “Parties”), as follows:
